Long-Term Dosing in Sickle Cell Disease Subjects with GBT440, a Novel HbS Polymerization Inhibitor
暂无分享,去创建一个
K. Bridges | K. Dufu | J. Howard | P. Telfer | J. Porter | A. Hutchaleelaha | M. Layton | D. Oksenberg | T. Mant | E. Ramos | J. Lehrer-Graiwer | C. Hemmaway | M. Awogbade | Mira P Patel | M. Tonda